EcoDrugPlus

Matrix Metalloproteinase-20-Like

Ensembl ID : ENSLACG00000015396
Gene Symbol: LOC102361531
3 Cross references
9 Possible Orthologues:

Matrix Metalloproteinase-20-Like

Ensembl ID : ENSLACG00000014804
Gene Symbol: LOC102362863
1 Cross references
196 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSLACG00000016133
Gene Symbol: MTOR
1 Cross references
217 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSLACG00000016586
Gene Symbol: MTOR
1 Cross references
217 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSLACG00000000435
Gene Symbol: MC4R
4 Cross references
121 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSLACG00000008992
Gene Symbol: MTNR1A
2 Cross references
205 Possible Orthologues:

Melatonin Receptor 1b

Ensembl ID : ENSLACG00000010559
Gene Symbol: MTNR1B
2 Cross references
107 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSLACG00000006241
Gene Symbol: MME
3 Cross references
236 Possible Orthologues:

Membrane Primary Amine Oxidase-Like

Ensembl ID : ENSLACG00000003823
Gene Symbol: LOC102366117
4 Cross references
410 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSLACG00000002702
Gene Symbol: METAP2
4 Cross references
220 Possible Orthologues:

Microtubule-Associated Protein Tau B

Ensembl ID : ENSLACG00000014454
Gene Symbol: MAPTB
3 Cross references
256 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSLACG00000013972
Gene Symbol: MAPK1
4 Cross references
213 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).